Sonohysterography Compared With Endometrial Biopsy for Evaluation of the Endometrium in Tamoxifen-Treated Women

Journal of Ultrasound in Medicine

Volumn 22, Issue 11, 2003, Pages 1173-1179

  Hann, Lucy E ^a   Kim, Cathleen M ^a   Gonen, Mithat ^a   Barakat, Richard ^a   Choi, Patricia H ^a   Bach, Ariadne M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Endometrial biopsy; Endometrial polyp; Sonohysterography; Tamoxifen

Indexed keywords

BIOPSY; PATHOLOGY; SENSITIVITY ANALYSIS;

SONOOHYSTEREGRAPHY;

ULTRASONIC APPLICATIONS;

TAMOXIFEN;

ADULT; AGED; ARTICLE; BLEEDING; DIAGNOSTIC ACCURACY; ENDOMETRIAL DISEASE; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE; HUMAN; HUMAN TISSUE; HYSTEROGRAPHY; HYSTEROSCOPY; INTERMETHOD COMPARISON; MENOPAUSAL SYNDROME; NORMAL HUMAN; POLYP;

EID: 0242354003     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2003.22.11.1173     Document Type: Article

References (29)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 1-15, 71-85.
2. Osborne CK. Drug therapy: tamoxifen in the treatment of breast cancer. N Engl J Med 1998; 339: 1609-1618.
3. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998; 90:1371-1388.
4. Barakat RR. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer. J Clin Oncol 1999; 17:1967-1968.
5. Ascher SM, Imaoka I, Lage JM. Tamoxifen induced uterine abnormalities: the role of imaging. Radiology 2000; 214:29-38
6. Bergman L, Beelen M, Gallee M, Hollema H, et al. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet 2000; 356: 881-887.
7. Berliere M, Charles A, Galant C, Donnez J. Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol 1998; 91:40-44.
8. Hulka CA, Hall DA. Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. AJR Am J Roentgenol 1993; 160:809-812.
9. Kedar R, Bourne TH, Collins WP, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994; 343:1318-1321.
10. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B14. J Natl Cancer Inst 1994; 86:527-537.
11. Fong K, Kung R, Lytwyn A, et al. Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen. Radiology 2001; 220:765-773.
12. Deligdisch L, Kalir T, Cohen C, de Latour M, Le Bouedec G, Penault-Llorca F. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 2000; 78: 181-186.
13. Hann L, Geiss C, Bach A, Tao Y, Baum H, Barakat R. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR Am J Roentgenol 1997; 168:657-661.
14. Hann L, Gretz E, Bach A, Francis S. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen. AJR Am J Roentgenol 2001; 177:337-342.
15. Barakat RR, Gilewski TA, Almadrones L, et al. Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol 2000; 18:3459-3463.
16. Franchi M, Ghezzi F, Donadello N, Zanaboni F, Beretta P, Bolis P. Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease. Obstet Gynecol 199; 93:1004-1008.
17. Schwartz LB, Snyder J, Horan C, Porges RF, Nachtigall LE, Goldstein SR. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation or asymptomatic postmenopausal breast cancer patients on tamoxifen. Ultrasound Obstet Gynecol 1998; 11:48-53.
18. Laifer-Narin SL, Ragavendra N, Lu DS, Sayre J, Perrella RR, Grant EG. Transvaginal saline hysterosonography: characteristics distinguishing malignant and various benign conditions. AJR Am J Roentgenol 1999; 172:1513-1520.
19. Achiron R, Lipitz S, Sivan E, Goldenberg M, Mashiach S. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med 1995; 14: 685-688.
20. Lev-Toaff A, Toaff M, Liu JB, Merton D, Goldberg B. Value of sonohysterography in the diagnosis and management of abnormal uterine bleeding. Radiology 1996; 201:179-184.
21. O'Connell LM, Fries MH, Zeringue E, Brehm W. Triage of abnormal postmenopausal bleeding: a comparison of endometrial biopsy and transvaginal sonohysterography versus fractional curettage with hysteroscopy. Am J Obstet Gynecol 1998; 178: 956-961.
22. Dubinsky T, Stroehlein K, Abu-Ghazzeh Y, Parvey HR, Maklad N. Prediction of benign and malignant endometrial disease: hysterosonographic-pathologic correlation. Radiology 1999; 210:393-397.
23. Tepper R, Beyth Y, Altaras M, et al. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol 1997; 64:386-391.
24. Cohen I, Rosen D, Tepper R, et al. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 1993; 12:275-280.
25. Timmerman D, Deprest J, Bourne T, Van den Berghe I, Collins WP, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 1998, 179:62-70.
26. Shipley CF III, Simmons CL, Nelson GH. Comparison of transvaginal sonography with endometrial biopsy in asymptomatic postmenopausal women. J Ultrasound Med 1994; 13:99-104.
27. Schlesinger C, Kamoi S, Ascher SM, Kendell M, Lage JM, Silverberg SG. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol 1998; 17:302-311.
28. Ramondetta LM, Sherwood JB, Dunton CJ, Palazzo JP. Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol 1999; 180:340-341.
29. Cohen I, Bernheim J, Azaria R, Tepper R, Sharony R, Beyth Y. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients. Gynecol Oncol 1999; 75:136-141.